Schedule 13D ownership disclosure

Amneal Pharmaceuticals Inc

Security class unavailable · CUSIP: 03168L105

Event date: 2019-07-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,213,367
Percent of class
12.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-19-005210
Form type
SC 13D/A
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Jul 19, 2019
Reporting period
Jul 18, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub